The sales of the Slovenian pharma group Krka grew by 21% year-on-year in 2014 in Romania, to EUR 61.2 million.

They represent 40% of the group’s southeastern European sales, according to a Krka report.

The company’s portfolio includes prescription and non-prescription drugs, as well as vet products.

In the whole region, Krka sold drugs worth EUR 155.3 million, which represent 13% of its global sales. These amount to EUR 1.19 billion.

Krka ranks 10th on the Romanian market, with a 3% market share, according to market analysis company Cegedim.

editor@romania-insider.com